НАУКОВО-КЛІНІЧНА ДЕКЛАРАЦІЯ КОНЦЕПЦІЇ «РЕПРОВІТАЛІЗАЦІЇ» ТА СИСТЕМИ ПРЕЦИЗІЙНОГО ТЕМПОРАЛЬНО-МЕТАБОЛІЧНОГО МЕНЕДЖМЕНТУ В РЕПРОДУКТОЛОГІЇ ТА АНДРОЛОГІЇ: ПРАВОВИЙ ТА АВТОРСЬКИЙ ЗАХИСТ ПЕРШОДЖЕРЕЛА

This document declares and secures the exclusive intellectual property right to the scientific term and clinical model "Reprovitalization".

Reprovitalization is a scientifically grounded, fundamental epigenetic process of systemic restoration of biological youth, mitochondrial bioenergetics, and the genetic competence of the human reproductive system. The process is implemented by eliminating latent metabolic traps, tissue lipotoxicity, low-grade inflammation, and fully restoring the circadian synchrony of central and peripheral molecular oscillators.

Unlike classical assisted reproductive technologies (ART), which empirically exploit functionally exhausted gonads, Reprovitalization shifts the focus to designing an ideal metabolic and temporal environment (Chrono-Intelligence Ecosystem). This allows Leydig, Sertoli, and granulosa cells to independently restore physiological homeostasis and realize their reproductive potential.

Legal protection applies to the term "Reprovitalization" itself, as well as the following proprietary concepts, technological modules, and their linguistic variations:

1. PMOS (Polyendocrine Metabolic Ovarian Syndrome) — a complete replacement of the outdated term PCOS, which defines ovaries not as the root cause, but as a target organ of global metabolic chaos.

2. MAH-PMOS (Metabolically-Associated Hypogonadism / Polyendocrine Metabolic Ovarian-Analogue Syndrome) — a mirror pathogenetic analogue of female PMOS in the male reproductive system.

3. The OS(P)MOS Protocol (A Personalized Approach to the Diagnosis, Treatment, and Prevention of Polyendocrine Metabolic Ovarian Syndrome through the prism of Repronutriciology).

4. Chronoandrology and Chronoreproductology — areas of clinical time-management of the reproductive axis based on the regulation of peripheral molecular clocks (CLOCK, BMAL1, PER, CRY).

5. S.Y.N.C.H.R.O. and CIE (Chrono-Intelligence Ecosystem) Systems — algorithms for the temporal synchronization of metabolism and hormone secretion.

2. SCIENTIFIC-CLINICAL JUSTIFICATION OF PATHOGENESIS AND BIORHYTHM SYNERGY

The concept is based on the proven interaction between the central oscillator (suprachiasmatic nucleus of the hypothalamus) and local molecular clocks expressed directly in gonad tissues. Chronic desynchronosis (social jetlag, sleep disorders, insulin resistance) destroys the epigenetic control of these genes, blocking the circhoral (pulsatile) mode of GnRH release.

In the male body, this failure triggers the MAH-PMOS cascade, the clinical justification of which consists of the following stages:

1. Tissue Insulin Resistance: Cells lose sensitivity to insulin, activating low-grade systemic inflammation.

2. Aromatase Trap: Due to visceral lipotoxicity, the enzyme aromatase (gene CYP19A1) is overexpressed, aggressively converting endogenous testosterone into female estrogens.

3. Hypothalamic-Pituitary Blockade: Hyperestrogenism, via negative feedback, suppresses the brain's release of LH and FSH, shutting down hormonal support for the testes.

4. Cellular Collapse and Oxidative Stress: Leydig and Sertoli cells undergo dystrophy, leading to a critical increase in sperm DNA fragmentation (SDF) and a complete loss of genetic competence of the material, despite maintaining standard semen analysis parameters.

Similar metabolic chaos in the female body leads to follicular arrest, androgenization, and mitochondrial decay of oocytes (PMOS). Treatment of both conditions requires Repronutriciology tools implemented in The OS(P)MOS Protocol.

3. METHODOLOGICAL STRUCTURE AND CLINICAL STAGES OF "THE OS(P)MOS FRAMEWORK"

Reprovitalization for a couple or individual patient is implemented through four strictly sequential stages, each with fundamental clinical and chronobiological justification:

• Stage 1: Multimodal Metabolic and Chronobiological Audit Verification of hidden molecular blocks to fertility: assessment of insulin resistance indices (HOMA-IR, TyG), the pool of free fatty acids, and markers of inflammation (hs-CRP, IL-6). Mapping the daily curves of melatonin and cortisol is mandatory to identify latent chronodesynchronosis that destroys the ultrastructure of gametes.

• Stage 2: Destruction of Metabolic Traps (Receptor Reset) Aimed at breaking the insulin blockade and aromatase trap. The use of chronopharmacologically titrated insulin sensitizers and specific antioxidants within the S.Y.N.C.H.R.O. system occurs during moments of highest aromatase enzyme vulnerability, restoring hormonal balance without the use of aggressive empirical hormone therapy.

• Stage 3: Epigenetic Activation and Gamete Repair Ensures a reduction in the sperm DNA fragmentation index (SDF) in men and restoration of the mitochondrial pool of oocytes in women. Through Repronutriciology tools (methyl group donors, targeted nutrigenomic protectors), follicular and testicular fluids are saturated with antioxidant compounds during critical time phases of cell meiotic division, returning them to genetic competence.

• Stage 4: Stabilization of Reprolongevity Fixation of epigenetic markers, preservation of telomere length, and prolongation of the patients' reproductive window. This stage is based on the final synchronization of metabolism with natural light-dark cycles (Chrono-Intelligence Ecosystem), which prevents premature endocrine aging of the gonads and forms a stable gestational readiness of the organism.

4. IMPLEMENTATION IN PROGRAMS OF DELAYED PARENTHOOD AND PREGNANCY PLANNING

The Reprovitalization concept fundamentally transforms the approach to social or medical gamete freezing (cryopreservation) and conscious pregnancy planning at an older reproductive age, highlighting three vectors of temporal protection:

• Pre-Cryo Construction (Epigenetic Selection): Traditional "blind" freezing of eggs or sperm under conditions of metabolic chaos preserves cells with hidden ultrastructural defects. Reprovitalization 2–3 months before puncture ensures the collection of gametes with a maximum density of healthy mitochondria, which increases their survival rate after decryopreservation and reduces the risk of aneuploidy.

• Endocrine Buffer (Somatic Status Protection): Controlled ovarian stimulation procedures are a massive hormonal load. Reprovitalization creates a metabolic buffer (specifically through synchronization of liver molecular clocks responsible for steroid detoxification), minimizing risks of thrombophilia, ovarian hyperstimulation syndrome (OHSS), and exhaustion of the gonad receptor pool.

• Gestational Restoration (Soil Preparation): A frozen gamete does not age, but the body of a woman returning for it years later undergoes chronological and vascular changes. Reprovitalization before cryotransfer is aimed at restoring the angiotectonics and receptivity of the endometrium, eliminating tissue insulin resistance, and bringing the immune system to a state of gestational tolerance, which excludes risks of missed pregnancies and early miscarriages.

5. LEGAL MANDATE, JURISDICTION, AND STRICT PROTECTION AGAINST PLAGIARISM AND MIMICRY

ATTENTION! IMPERATIVE LEGAL CAVEAT AND COPYRIGHT PROTECTION

This scientific document is an object of exclusive copyright belonging to Viktoriya Hudziak from the moment of its deposition and publication in the Zenodo international repository with the assignment of an international DOI index. Any full or partial use of materials, clinical schemes, stages, or logical blocks without direct written approval from the Author is strictly prohibited and is prosecuted by law in accordance with international intellectual property protection legislation (Berne Convention, Universal Copyright Convention, the laws of Ukraine "On Copyright and Related Rights").

5.1. Prohibition on the use of similar word combinations and Phrasal and Semantic Mimicry: Legal protection under this mandate extends not only to identical text copying but also to the prohibition of using similar word combinations, synonymic substitutions, artificial paraphrasing, and generative modifications (by artificial intelligence) that attempt to convey the essence of the "Reprovitalization" concept and the OS(P)MOS protocol under other names.

Without the Author's licensing agreement, it is prohibited to use the following linguistic and semantic constructions, as well as combinations derived from them, in the public, commercial, medical, or scientific space:

• Any combination of the words "reproductive" / "repro" + "vitalization" / "revitalization" / "restoration of cellular youth of gonads" / "biological rejuvenation of fertility";

• Derivatives of the term PMOS, such as: "Polyendocrine Ovarian Syndrome," "Metabolic Ovarian Syndrome," "Multiendocrine Gonad Dysfunction";

• Derivatives and synonyms of the term MAH-PMOS, including: "Male PMOS," "Andrological PMOS," "Ovarian-analogue male syndrome," "Mirror-type metabolic hypogonadism";

• Stages of clinical management similar in structure or borrowed from the text that copy the four-level system: "Metabolic Audit — Destruction of Traps (Reset) — Epigenetic Gamete Repair — Stabilization of Reprolongevity";

• Terminological borrowings of the concepts "Chronoandrology" and "Chronoreproductology" in combination with clinical Repronutriciology methods.

5.2. Liability for violations: Detection of the use of the aforementioned concepts, similar word combinations, or the logical structure of The OS(P)MOS Protocol by third-party medical institutions, private clinicians, influencers, or scientists without an official reference to the primary source (this Zenodo publication) is a direct violation of intellectual property rights. Such actions are classified as plagiarism, unfair competition, and deception of patients. The RIGHTS HOLDER reserves the right to defend their interests in court, including the demand for compensation for damages incurred, lost profits, and public retraction in international registries.

RIGHTS HOLDER / AUTHOR: _______________________ / Hudziak, V. V. / Date of registration in the repository: May 19, 2026 Status of document: Official primary source

OFFICIAL DEPOSITORY SEAL (Captured by Zenodo blockchain via DOI identifier: 10.5281/zenodo.20234565. Plagiarism attempts are automatically recorded and are subject to international DMCA copyright protection sanctions)